1 year return (CAGR)
-
LB Pharmaceuticals Inc Common Stock Exchange (NASDAQ, USD)
LBRX
44.63
-1.62 (-3.50%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.44B
Price/Sales
-
Ent value
1.19B
Price/Book
4.33
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 46.80 |
| Daily high | 47.34 |
| Daily low | 44.40 |
| Daily Volume | 208K |
| All-time high | 49.48 |
| 1y analyst estimate | 53.38 |
| Beta | - |
| EPS (TTM) | -2.84 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| LBRX | S&P500 | |
| Current price drop from All-time high | -9.80% | -1.75% |
| Highest price drop | -17.82% | -56.47% |
| Date of highest drop | 2 Jun 2026 | 9 Mar 2009 |
| Avg drop from high | -5.04% | -10.68% |
| Avg time to new high | 5 days | 12 days |
| Max time to new high | 40 days | 1805 days |
News
